Sigyn Therapeutics (OTCMKTS:SIGY) and Quipt Home Medical (NASDAQ:QIPT) Head-To-Head Comparison

Sigyn Therapeutics (OTCMKTS:SIGY) and Quipt Home Medical (NASDAQ:QIPT) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, risk, dividends and institutional ownership.

Insider and Institutional Ownership

10.0% of Sigyn Therapeutics shares are held by institutional investors. Comparatively, 42.9% of Quipt Home Medical shares are held by institutional investors. 78.5% of Sigyn Therapeutics shares are held by insiders. Comparatively, 4.2% of Quipt Home Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Sigyn Therapeutics and Quipt Home Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sigyn Therapeutics	N/A	N/A	-958.06%
Quipt Home Medical	-1.50%	-3.57%	-1.54%

Risk & Volatility

Sigyn Therapeutics has a beta of -1.68, indicating that its share price is 268% less volatile than the S&P 500. Comparatively, Quipt Home Medical has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Sigyn Therapeutics and Quipt Home Medical, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sigyn Therapeutics	0	0	0	0	N/A
Quipt Home Medical	0	1	1	0	2.50

Quipt Home Medical has a consensus price target of $10.00, suggesting a potential upside of 189.02%. Given Quipt Home Medical’s higher possible upside, analysts clearly believe Quipt Home Medical is more favorable than Sigyn Therapeutics.

Valuation and Earnings

This table compares Sigyn Therapeutics and Quipt Home Medical’s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sigyn Therapeutics	N/A	N/A	-$4.15 million	($3.60)	-1.60
Quipt Home Medical	$221.74 million	0.66	-$2.78 million	($0.09)	-38.44

Quipt Home Medical has higher revenue and earnings than Sigyn Therapeutics. Quipt Home Medical is trading at a lower price-to-earnings ratio than Sigyn Therapeutics, indicating that it is currently the more affordable of the two stocks.

Summary

Quipt Home Medical beats Sigyn Therapeutics on 8 of the 12 factors compared between the two stocks.

About Sigyn Therapeutics

Sigyn Therapeutics, Inc., a development-stage company, provides therapeutic solutions in the United States. Its lead product candidate is Sigyn Therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, community acquired pneumonia, drug resistant bacterial infections, and emerging pandemic threats. The company is also involved in evaluating the Sigyn Therapy to address various therapeutic targets, including endotoxin; peptidoglycan and lipoteichoic acid; viral pathogens; hepatic toxins; and tumor necrosis factor alpha, interleukin-1 beta, and interleukin 6, which are pro-inflammatory cytokines. In addition, it develops ChemoPrep to enhance the tumor site delivery of chemotherapy; ChemoPure to reduce treatment toxicity and inhibit the spread of cancer metastasis; and ImmunePrep to enhance the potential efficacy of immunotherapeutic antibodies. Sigyn Therapeutics, Inc. was founded in 2019 and is headquartered in San Diego, California.

About Quipt Home Medical

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.